))
Episode 26: Burden and Pathophysiology of APOL1 Kidney Disease
Manage episode 516154465 series 3689489
Content provided by KDIGO Communications. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KDIGO Communications or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
This is the first episode of a three-part KDIGO Conversations in Nephrology series on APOL1 kidney disease. Host Kirk Campbell, MD (University of Pennsylvania, United States), speaks with Bessie Young, MD (University of Washington, United States) about the discovery, burden, and biology of APOL1 kidney disease. Their discussion explores how APOL1 variants contribute to increased kidney disease risk in people of African ancestry, recent findings on protective variants, and ongoing research toward targeted therapies.
Learn more and access resources from the KDIGO Controversies Conference on APOL1 Kidney Disease: https://kdigo.org/conferences/apol1-kidney-disease/
This podcast was supported by Vertex Pharmaceuticals.
28 episodes
Share
